Vector Science and Therapeutics invests in Scoreboard via SAFE agreement

PUBT · 1d ago
Vector Science and Therapeutics invests in Scoreboard via SAFE agreement
  • Vector Science and Therapeutics entered a strategic relationship with Scoreboard, Inc., co-founded by NBA Hall of Famer Gary Payton.
  • Vector made a minority equity investment in Scoreboard via a Simple Agreement for Future Equity (SAFE).
  • Partnership targets peptide-based products for athletic performance, recovery, longevity using peptides formulated and manufactured by Vector.
  • Vector plans to apply its delivery and formulation IP to support shelf-stable liquid and gel peptide formats for Scoreboard products.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vector Science and Therapeutics Corp. published the original content used to generate this news brief via CNW (Ref. ID: 202610070745CANADANWCANADAPR_C6645) on October 07, 2026, and is solely responsible for the information contained therein.